abstract |
The present application relates to calcium channel inhibitors comprising compounds of formula (I), formula (II), formula (III), or formula (IV), n n n n n n n n n n wherein L 1 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R c are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions. |